FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Wizcure Pharmaa Private Vista Meibo Tears Propylene Glycol 0 Recall

Vista Meibo Tears Propylene Glycol 0

Wizcure Pharmaa Private Limited · Bhiwadi, N/A

Risk level
Class II
Reported by FDA
Mar 4, 2026
Recall ID
D-0348-2026
Check your lot numberHow we source this data

Summary

Wizcure Pharmaa Private recalled Vista Meibo Tears Propylene Glycol 0 starting Dec 31, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0348-2026 on Mar 4, 2026. Reason: Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices. Status: Ongoing.

Why it was recalled

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Product description

Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Revitalizing Formula, 10 ml (1/3 fl.oz.), Wizcure Pharmaa PVT. LTD., H-881, Phase 3, RIICO Industrial Area, Bhiwadi-301019, India, Manufactured for and distributed by: hi-health, 15207 N. 75th Street, Suite #104, Scottsdale, AZ 85260, NDC 77790-003-10.

Lot numbers, UPCs & expiration codes

All lots

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0348-2026
Classification
Class II
Status
Ongoing
Recall initiated
Dec 31, 2025
FDA report date
Mar 4, 2026
Quantity
11,520 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Wizcure Pharmaa Private Limited

Original FDA data

Every field from FDA enforcement report D-0348-2026, exactly as published.

Show all FDA fields
City
Bhiwadi
Status
Ongoing
Country
India
Event ID
98253
Address
H - 881
Code information
All lots
Report date
Mar 4, 2026
Product type
Drugs
Recall number
D-0348-2026
Classification
Class II
Recalling firm
Wizcure Pharmaa Private Limited
Product quantity
11,520 cartons
Reason for recall
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Revitalizing Formula, 10 ml (1/3 fl.oz.), Wizcure Pharmaa PVT. LTD., H-881, Phase 3, RIICO Industrial Area, Bhiwadi-301019, India, Manufactured for and distributed by: hi-health, 15207 N. 75th Street, Suite #104, Scottsdale, AZ 85260, NDC 77790-003-10.
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Dec 31, 2025
Initial firm notification
Letter
Center classification date
Feb 25, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0348-2026, published Mar 4, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls